Supernus Pharmaceuticals reported $663.89M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Aerie Pharmaceuticals AERI:US USD 302.81M 8.6M
Ani Pharmaceuticals ANIP:US USD 309.38M 13.02M
Aurora Cannabis Inc ACB:CN CAD 681.83M 63.29M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Canopy Growth Corp WEED:CN CAD 1.54B 55.4M
Cara Therapeutics CARA:US USD 186.78M 10.61M
Corcept Therapeutics CORT:US USD 452.4M 33.36M
Eisai 4523:JP JPY 585.38B 35.57B
Eli Lilly And LLY:US USD 17.64B 524.7M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Horizon Pharma HZNP:US USD 3.41B 208.92M
Lannett LCI:US USD 264.66M 25.46M
Marinus Pharmaceuticals MRNS:US USD 177.01M 75.91M
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Revance Therapeutics RVNC:US USD 415.59M 154.65M
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
United Therapeutics UTHR:US USD 3.06B 372.1M
Xeris Pharmaceuticals Inc XERS:US USD 148.92M 12.29M